Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myotonic Dystrophy, Type 1 (DM1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07362316
What this trial is testing

Longitudinal Evaluation of Neuromuscular Involvement in Type 1 Myotonic Dystrophy

Who this might be right for
Steinert Myotonic Dystrophy
Institut de Myologie, France 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06316531
What this trial is testing

A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 274
Testing effectiveness (Phase 2)Looking for participantsNCT06844214
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy
Sanofi 32
Early research (Phase 1)Study completedNCT01976169
What this trial is testing

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

Who this might be right for
Advanced Breast Cancer
University of Texas Southwestern Medical Center 29
Not applicableStudy completedNCT03589677
What this trial is testing

Brain Involvement in Myotonic Dystrophy Type I: From Functional Neuroimaging to the Impact on Quality of Life

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)
IRCCS San Camillo, Venezia, Italy 50
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Large-scale testing (Phase 3)Looking for participantsNCT06830889
What this trial is testing

BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer With Residual Invasive Cancer After Neoadjuvant Therapy

Who this might be right for
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 1,450
Large-scale testing (Phase 3)Study completedNCT01939561
What this trial is testing

Lamotrigine as Treatment of Myotonia

Who this might be right for
Dystrophia Myotonica Type 1Myotonia CongenitaParamyotonia Congenita+2 more
Grete Andersen, MD 27
Testing effectiveness (Phase 2)Study completedNCT03530696
What this trial is testing

T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer

Who this might be right for
HER2-positive Breast CancerBreast CancerBreast Cancer Stage+3 more
University of Arizona 55
Early research (Phase 1)Study completedNCT04509596
What this trial is testing

DZD1516 in Combination With Trastuzumab and Capecitabine, or in Combination With T-DM1, in Patients With Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Dizal Pharmaceuticals 23
Not applicableStudy completedNCT04187482
What this trial is testing

Myotonic Dystrophy Type 1 Aerobic Exercise Study

Who this might be right for
Myotonic Dystrophy 1Muscular Dystrophies
McMaster University 13
Not applicableLooking for participantsNCT06693037
What this trial is testing

Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy

Who this might be right for
HER2-positive Breast Cancer
Shu Wang 2,092
Early research (Phase 1)Study completedNCT02251457
What this trial is testing

Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1

Who this might be right for
Myotonia CongenitaParamyotonia CongenitaMyotonic Dystrophy 1
Ohio State University 35
Not applicableStudy completedNCT01136330
What this trial is testing

DM1 Heart Registry - DM1 Respiratory Registry

Who this might be right for
Myotonic Dystrophy
Institut de Myologie, France 914
Not applicableLooking for participantsNCT06747884
What this trial is testing

Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension

Who this might be right for
Congenital Myotonic DystrophyChildhood Myotonic DystrophyMyotonic Dystrophy
Virginia Commonwealth University 200
Not applicableUnknownNCT03155594
What this trial is testing

CGM to Aid Transition From Inpatient to Outpatient

Who this might be right for
Diabete Mellitus
Methodist Medical Center of Illinois 15
Testing effectiveness (Phase 2)Study completedNCT00509769
What this trial is testing

Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 112
Testing effectiveness (Phase 2)Looking for participantsNCT06300307
What this trial is testing

Study of ATX-01 in Participants With DM1

Who this might be right for
Myotonic Dystrophy 1
ARTHEx Biotech S.L. 56
Not applicableUnknownNCT06378216
What this trial is testing

Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]

Who this might be right for
Myotonic Dystrophy 1
IRCCS Eugenio Medea 30
Testing effectiveness (Phase 2)Looking for participantsNCT07220603
What this trial is testing

An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)

Who this might be right for
Myotonic Dystrophy 1
PepGen Inc 48
Next Page